{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":25,"n_cols":5,"rows_kept":25,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[10,2,10,3],[12,2,12,3],[13,2,13,3],[17,2,17,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910300071703321"]
[null,null,"Titolo",null,"Schizophrenia : Recent Advances in Diagnosis and Treatment / / edited by Philip G. Janicak, Stephen R. Marder, Rajiv Tandon, Morris Goldman"]
[null,null,"Pubbl/distr/stampa",null,"New York, NY : , : Springer New York : , : Imprint : Springer, , 2014"]
[null,null,"ISBN",null,"1-4939-0656-9"]
[null,null,"Edizione",null,"[1st ed. 2014.]"]
[null,null,"Descrizione fisica",null,"1 online resource (333 p.)"]
[null,null,"Disciplina",null,"610"]
[{"$nulls":4},"615.78"]
[{"$nulls":4},"616.89"]
[{"$nulls":4},"616.8914"]
[null,null,"Soggetti",null,"Psychiatry"]
[{"$nulls":4},"Psychotherapy"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references at the end of each chapters and index."]
[null,null,"Nota di contenuto",null,"\"\"Preface\"\"; \"\"Contents\"\"; \"\"Contributors\"\"; \"\"Part I: Overview\"\"; \"\"Chapter 1: Introduction\"\"; \"\"Clinical Features\"\"; \"\" Epidemiology and Genetic and Environmental Risk Factors\"\"; \"\" Overview of Neurobiology\"\"; \"\"Neurotransmission\"\"; \"\" Genetics\"\"; \"\" Neuroimaging\"\"; \"\" Endophenotypes\"\"; \"\" Management of Schizophrenia\"\"; \"\" Complications Associated with Schizophrenia and Its Treatment\"\"; \"\"Long-Term Management\"\"; \"\"References\"\"; \"\"Chapter 2: The Evolving Nosology of Schizophrenia: Relevance for Treatment\"\"; \"\"Introduction\"\""]
[{"$nulls":4},"\"\" The Concept of Schizophrenia from the Nineteenth Century to DSM-IV and ICD-10\"\"\"\" The Present: DSM-5 and Towards ICD-11\"\"; \"\"Changes in Characteristic Symptoms of Schizophrenia in DSM-5 and ICD-11\"\"; \"\" Elimination of Classic Subtypes of Schizophrenia in DSM-5 and ICD-11\"\"; \"\" Addition of Psychopathological Dimensions of Schizophrenia\"\"; \"\" Attenuated Psychosis Syndrome\"\"; \"\" Treatment Implications of Current Conceptualization of Schizophrenia: 2014 and Beyond\"\"; \"\"References\"\"; \"\"Part II: Recent Research into thePathophysiology of Schizophrenia\"\"; \"\"Chapter 3: Overview of Neurobiology\"\""]
[{"$nulls":4},"\"\"Introduction\"\"\"\"Identifying Findings Is Not the Same as Identifying an Abnormality\"\"; \"\" To Determine If a Finding Reflects Pathology, Learn About Its Regulation\"\"; \"\" Some Abnormalities May Be Epiphenomena "]
[{"$nulls":4},"But Still Provide Clues About Mechanisms\"\"; \"\" Heterogeneity Obscures Findings by Mixing Patients with Deficient and Adaptive Function\"\"; \"\" Compensatory Responses May Identify Potential Treatment Interventions for Other Patients\"\"; \"\" How Does One Relate Underlying Neurobiology to Treatment of Schizophrenia\"\"; \"\" Conclusion\"\"; \"\"References\"\""]
[{"$nulls":4},"\"\"Chapter 4: Pathophysiology of Schizophrenia\"\"\"\"Introduction\"\"; \"\" Brain Structure\"\"; \"\"Gray Matter\"\"; \"\" White Matter\"\"; \"\" Summary\"\"; \"\" Brain Function\"\"; \"\"Functional and Molecular Imaging\"\"; \"\" Summary\"\"; \"\" Neurophysiology\"\"; \"\"P300\"\"; \"\" Prepulse Inhibition of Startle\"\"; \"\" P50 Auditory-Evoked Potential Suppression\"\"; \"\" Mismatch Negativity\"\"; \"\" Cortical Oscillations and Neural Synchrony\"\"; \"\" Summary\"\"; \"\" Oxidative, Immunological, and Neuroendocrine Abnormalities\"\"; \"\" Neurotransmitter Systems\"\"; \"\"Neurochemical Imaging\"\"; \"\" Dopamine\"\"; \"\" Gamma Aminobutyric Acid\"\"; \"\" Glutamate\"\""]
[{"$nulls":4},"\"\" Summary\"\"\"\" Neuropathology\"\"; \"\" Neuroplasticity\"\"; \"\" Models of Pathogenesis\"\"; \"\"Summary\"\"; \"\" Conclusion\"\"; \"\"Knowledge Gaps and Future Steps\"\"; \"\"References\"\"; \"\"Chapter 5: Genetics of Schizophrenia\"\"; \"\"Introduction\"\"; \"\" Genetic Epidemiology\"\"; \"\" Molecular Approaches: Linkage\"\"; \"\" Molecular Approaches: Candidate Gene Association\"\"; \"\" Molecular Approaches: Genome-Wide Association Studies\"\"; \"\" Genetic Relationships to Bipolar Disorder\"\"; \"\" Clinical Applications and Future Directions\"\"; \"\" Conclusion\"\"; \"\"Glossary\"\"; \"\"References\"\""]
[{"$nulls":4},"\"\"Chapter 6: Recent Advances in Neuroimaging Biomarkers of Schizophrenia\"\""]
[null,null,null,"Sommario/riassunto","Schizophrenia: Recent Advances in Diagnosis and Treatment is a major addition to the literature, offering practical, comprehensive coverage of diagnosis and treatment options, genetic issues, neuroimaging, long-term management of schizophrenia, and future directions and predictions of how clinical care of schizophrenia will change.  The book is divided into five sections. Section 1 summarizes the present state of knowledge about the diagnosis and treatment of schizophrenia. This includes recent changes in the DSM 5 categorization of schizophrenia and its implications for treatment. Section 2 considers recent discoveries into its pathoetiology, including the status of biological markers, genetics and neuroimaging as they relate to diagnosis and potential novel therapeutic approaches. Section 3 explores the optimization of present therapeutic approaches; novel treatments; and management of the substantial risks associated with both the illness and its present therapies. Section4 discusses progress in the long-term management of schizophrenia, focusing on biological and psychotherapeutic strategies to improve functioning and facilitate recovery.  Section 5 considers future directions and predictions of how diagnosis and treatment of schizophrenia will change.  An invaluable addition to the field, Schizophrenia: Recent Advances in Diagnosis and Treatment is a definitive resource that will be of great interest to all clinicians caring for patients with schizophrenia."]